Vol 22, No 1 (2021)

Table of Contents

Original research

A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel
Cristian Scatena, Roberto Ravasio, Paola Raimondo, Mario Giuliano
HTML PDF
Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy
Massimiliano Povero, Lorenzo Pradelli, Andrea Serra, Francesca Fanelli, Luca Gazzi
HTML PDF
Osteoarthritis in Italy: Impact on Health-Related Quality of Life and Health Care Resources
Patrizia Berto, Maria Domenica Sanna, James Jackson, Mia Berry, Jessica Jackson
HTML PDF